BridgeMD
New treatment option for Scleroderma Systemic
Official title Effect of the Use of Specific Oral Hygiene Devices on Gingival Health Among Patients With Systemic Sclerosis
ClinicalTrials.gov ID: NCT04627857
What this study is testing
- What it's testing
- Systemic sclerosis is a rare multisystem connective-tissue disorder characterized by three major pathological hallmarks: widespread fibrosis, vasculopathy and immunological abnormalities. This condition has multiple effects on the orofacial region that is involved in approximately 80% of the patients with a significant impact on the quality of life.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adult male or female ≥ 18 years (18th birthday completed)
- Affiliation to a social welfare system
- Signed informed consent form
- More than 12 natural teeth suitable for evaluation
- Systemic sclerosis with cutaneous involvement with a diagnosis based on American College of Rheumatology (ACR) and LeRoy and Metzger criteria
You likely can't join if
- Localized scleroderma or systemic sclerosis without cutaneous involvement ("sine scleroderma" limited form)
- Less than 12 natural teeth suitable for evaluation and/or mandibular/maxillary complete denture(s)
- Other progressive chronic illness /autoimmune disease other than systemic sclerosis (e.g. diabetes)
- Another cause of mucocutaneous sclerosis (e.g. radiotherapy involving the oro-facial region)
- Current use of sonic toothbrush and/or dental water flosser
- Severe manual handicap preventing the patient from holding a toothbrush with a large handle
See the full eligibility criteria
- Adult male or female ≥ 18 years (18th birthday completed)
- Affiliation to a social welfare system
- Signed informed consent form
- More than 12 natural teeth suitable for evaluation
- Systemic sclerosis with cutaneous involvement with a diagnosis based on American College of Rheumatology (ACR) and LeRoy and Metzger criteria
- Localized scleroderma or systemic sclerosis without cutaneous involvement ("sine scleroderma" limited form)
- Less than 12 natural teeth suitable for evaluation and/or mandibular/maxillary complete denture(s)
- Other progressive chronic illness /autoimmune disease other than systemic sclerosis (e.g. diabetes)
- Another cause of mucocutaneous sclerosis (e.g. radiotherapy involving the oro-facial region)
- Current use of sonic toothbrush and/or dental water flosser
- Severe manual handicap preventing the patient from holding a toothbrush with a large handle
- Oral antiseptics (e.g. chlorhexidin mouthwashes)
- Ongoing medical treatment inducing a significant modification of the gingival state (e.g. anti-epileptic drugs)
- Smoking (≥ 10 cigarettes per day)
- Impossibility to provide accurate information (e.g. emergency situation, comprehension difficulties)
- Individual under guardianship, curatorship or judicial protection
The study team makes the final eligibility decision.
Where it's taking place
- Strasbourg, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Strasbourg, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.